Effect of vitamin D supplementation in urinary incontinency
- Conditions
- urgent urinary incontinency.Urgency of urinationR39.15
- Registration Number
- IRCT20200417047109N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 90
Menopausal women between 50 and 80 years of age
Serum level of vitamin D3 below 30ng / ml
Urgent urinary incontinence of any degree
Written informed consent for participation in the study
Any underlying condition that impairs vitamin D absorption, such as IBD and gastric bypass surgery
Chronic liver or kidney disease
Any neurological disorder that affects the urinary system such as MS, degenerative muscle disorders, CVA, and Spinal cord injury
Diabetes
History of chronic cough or chronic constipation
History of vesiculovaginal fistula
Progesterone and estrogen supplement in the last six months
Urinary tract infection during the test
Severe bladder prolapse (stages 3 and 4 cystocele and apical).
Patients using diuretics
Not knowing Persian language
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum vitamin D level. Timepoint: Vitamin D level before and after 8 weeks of vitamin D administration. Method of measurement: Serum Level.;Severity of urinary incontinence symptoms before and after treatment. Timepoint: Before and after treatment. Method of measurement: Modified LUTS EPINCONT questionnaire (based on total incontinence frequency and leakage volume).;The degree of disturbance in the patient's quality of life due to urinary incontinency (before and after treatment). Timepoint: At the beginning of the study and after the end of treatment. Method of measurement: Modified LUTS EPINCONT questionnaire.
- Secondary Outcome Measures
Name Time Method